As of 4:02pm ET
| -0.89 / -1.81%|
The 7 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 70.00, with a high estimate of 75.00 and a low estimate of 64.00. The median estimate represents a +45.14% increase from the last price of 48.23.
The current consensus among 8 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.